CME: Clinical Perspectives on Pregnancy & MS Patients

Clinical Perspectives on Pregnancy & MS Patients

Clinical Perspectives on Pregnancy & MS Patients
RestartResume
Many MS patients have questions about how this disease affects childbearing—and vice versa. Are you prepared to answer their questions?

Available credits: 0.25

Time to complete: 15 Minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Pregnancy is a major point of discussion for all women of child-bearing age, and when you factor in diseases like multiple sclerosis, it only further complicates matters. Hear from experts Dr. Kerstin Hellwig, Dr. Jiwon Oh, and Dr. Shiv Saidha about their approach to managing MS patients before, during, and after pregnancy. 

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. 

    Shiv Saidha MBBCh, MD, MRCPI
    Associate Professor of Neurology,
    Division of Neuroimmunology and Neurological Infections
    Johns Hopkins Hospital
    Baltimore, MD

    Dr. Saidha has disclosed he receives consulting fees from Biogen, EMD Serono, Genetech, and Genzyme; contracted research from Biogen, and Genetech; and has ownership interest in JuneBrain LLC.

    Jiwon Oh, MD
    Assistant Professor, Department of Medicine
    University of Toronto
    Scientist, Li Ka Shing Knowledge Institute of St. Michael’s Hospital
    Neurologist, Division of Neurology, Department of Medicine, St. Michael’s Hospital, Toronto, Ontario

    Dr. Oh has disclosed that she receives consulting fees from Biogen-Idec, EMD Serono, Novarits, Roche, and Sanofi, she also receives research support from Biogen-IDEC and Roche. 

    Kerstin Hellwig, MD 
    St. Josef und St. Elizabeth Hospital
    Bochum, Germany

    Dr. Hellwig disclosed she receives consulting fees Bayer, Biogen, Genzyme, Merck, Novartis, and Teva; and contract research from Biogen and Novartis.

    Reviewers/Content Planners/Authors: 

    • Sean Barrett has nothing to disclose.
    • Ann Early has nothing to disclose.
    • Rob Braun has nothing to disclose.
    • Barry Fiedel, PhD has nothing to disclosed.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Demonstrate an improved ability to assess when continued use of a disease-modifying therapy (DMT) in a pre-pregnant, pregnant, and/or breastfeeding patient with multiple sclerosis (MS) may be appropriate.
    • Formulate family planning communication pathways with patients with MS of childbearing age.
  • Target Audience

    This activity is designed to meet the educational needs of neurologists, women's health professionals, nurses, general practitioners, and other professionals that treat women with multiple sclerosis.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 CreditsTM to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at mutualrecognition@uems.eu.

  • Provider(s)/Educational Partner(s)

    TOPEC Global designs educational activities based on evidence-based medicine, needs and gaps analyses, learner feedback, and more. Its mission is to serve as an innovative and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

  • Commercial Support

    This activity is supported by an independent educational grant from Merck KGaA, Darmstadt, Germany.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC Global. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of TOPEC Global you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

    Disclaimer: Some products discussed in this activity may not have received regulatory approval by the US FDA for the treatment of patients with Multiple Sclerosis. The FDA has stated that “good medical practice and the best interests of the patient require that physicians use legally available drugs, biologics and devices according to their best knowledge and judgement”.  

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Register

We’re glad to see you’re enjoying Omnia Education…
but how about a more personalized experience?

Register for free